“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says
In Brief: FDA Oncology Div. Director Burke To Leave; Reed Is Branch Chief; NCAB Blasts Tobacco
NCI To Lose 19% of Workforce Over Six Years, Broder Says
NCI Director May Alert Cancer Panel to Freeze On GS-13 Promotion
NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes
Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines
Congressional Report Days NCI Ignored Data, Procedure, In Changes To Screening Guidelines
DCPC To Merge Two Programs, Reorganizes Chemoprevention
Trending Stories
- Vinay Prasad’s CV inaccurately claims past membership on the President’s Cancer Panel
- Breakthrough Therapy designation, ASCO plenary, and NEJM publication notwithstanding, breast cancer drug camizestrant gets a No from ODAC
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - CDC’s recommendation to delay infant hepatitis B shot is likely to raise infections, JAMA studies show
- CBER Director Vinay Prasad dared to “say no to drugs”
- J. Craig Venter’s work was foundational to cancer advancement of the past 25 years









